{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:59:52Z","timestamp":1777121992909,"version":"3.51.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim is to access the real-world clinical management of physicians who treat Takayasu arteritis (TAK) and giant cell arteritis (GCA) after the publication of the Japanese Circulation Society (JCS) 2017 Guidelines for the Management of Vasculitis Syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This descriptive, cross-sectional study utilized self-administered electronic questionnaires, which were answered in February 2022 by physicians treating TAK or GCA and registered with Macromill Inc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 329 survey respondents were enrolled. The 2017 JCS Guidelines were the most commonly referenced information source for resolving clinical questions, accessed by 70% of respondents. Ophthalmoscopy was performed in only 50% of patients with TAK and in 70% for GCA. The median percentages of patients who underwent 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography for TAK and GCA patients were 23% and 20% at diagnosis, respectively, and 10% each at follow-up within 12\u2009months. Tocilizumab was the most frequently used medication in combination with glucocorticoids for both TAK and GCA, especially in remission induction therapy for relapsed patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The majority of physicians treating TAK and GCA referred to the 2017 JCS guidelines. This report clarified the current clinical practice for large vessel vasculitis in Japan, providing information for the next revision of the guidelines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roae034","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:45:55Z","timestamp":1712637955000},"page":"1194-1201","source":"Crossref","is-referenced-by-count":3,"title":["Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-2868","authenticated-orcid":false,"given":"Yoshiyuki","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences , Okayama,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-7494","authenticated-orcid":false,"given":"Takahiko","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-7678","authenticated-orcid":false,"given":"Haruhito A","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences , Okayama,","place":["Japan"]},{"name":"Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences , Okayama,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical and Dental University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Kawasaki Medical School , Kurashiki,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Saitama Medical Center, Saitama Medical University , Kawagoe,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women\u2019s Medical University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8404-2587","authenticated-orcid":false,"given":"Yoshikazu","family":"Nakaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute , Suita, Osaka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-2603","authenticated-orcid":false,"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-2954","authenticated-orcid":false,"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"2024110410415017100_R1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024110410415017100_R2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2024110410415017100_R3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4081\/reumatismo.2021.1470","article-title":"The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis","volume":"73","author":"Ughi","year":"2022","journal-title":"Reumatismo"},{"key":"2024110410415017100_R4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024110410415017100_R5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1082604","article-title":"Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis","volume":"9","author":"Haaversen","year":"2023","journal-title":"Front Med"},{"key":"2024110410415017100_R6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024110410415017100_R7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2024110410415017100_R8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"2024110410415017100_R9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1253\/circj.CJ-19-0773","article-title":"JCS 2017 guideline on management of vasculitis syndrome \u2013 digest version","volume":"84","author":"Isobe","year":"2020","journal-title":"Circ J"},{"key":"2024110410415017100_R10","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/mr\/roac118","article-title":"Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: a cross-sectional web-questionnaire survey","volume":"33","author":"Miyawaki","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2024110410415017100_R11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1346-8138.12971","article-title":"Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale-8","volume":"42","author":"Kaneko","year":"2015","journal-title":"J Dermatol"},{"key":"2024110410415017100_R12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdent.2020.103469","article-title":"Evidence-practice gap in minimal intervention dentistry: findings from a dental practice-based research network","volume":"102","author":"Kakudate","year":"2020","journal-title":"J Dent"},{"key":"2024110410415017100_R13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0021-5155(99)00110-0","article-title":"Importance of fluorescein angiographic study in evaluating early retinal changes in Takayasu disease","volume":"43","author":"Baba","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"2024110410415017100_R14","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0167-5273(98)00162-4","article-title":"Ophthalmological findings in patients with Takayasu disease","volume":"66","author":"Kiyosawa","year":"1998","journal-title":"Int J Cardiol"},{"key":"2024110410415017100_R15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006982-200104000-00006","article-title":"The clinical and ocular manifestations of Takayasu arteritis","volume":"21","author":"Chun","year":"2001","journal-title":"Retina"},{"key":"2024110410415017100_R16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/IAE.0b013e3181fe540b","article-title":"Ocular manifestations of Takayasu arteritis: a cross-sectional study","volume":"31","author":"Peter","year":"2011","journal-title":"Retina"},{"key":"2024110410415017100_R17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/09273948.2022.2072348","article-title":"Ocular manifestations in an Italian cohort of patients with Takayasu Arteritis","volume":"31","author":"Dammacco","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"2024110410415017100_R18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2024110410415017100_R19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine"},{"key":"2024110410415017100_R20","first-page":"524","article-title":"The association of vascular risk factors with visual loss in giant cell arteritis","volume":"56","author":"Yates","year":"2017","journal-title":"Rheumatology"},{"key":"2024110410415017100_R21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/rheumatology\/38.5.444","article-title":"New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography","volume":"38","author":"Blockmans","year":"1999","journal-title":"Rheumatology"},{"key":"2024110410415017100_R22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00004728-199901000-00004","article-title":"FDG-PET finding in early-phase Takayasu arteritis","volume":"23","author":"Hara","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"2024110410415017100_R23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9343(99)00424-6","article-title":"Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch","volume":"108","author":"Blockmans","year":"2000","journal-title":"Am J Med"},{"key":"2024110410415017100_R24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.2003.011692","article-title":"Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study","volume":"63","author":"Moosig","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2024110410415017100_R25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00259-003-1144-y","article-title":"Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI","volume":"30","author":"Meller","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024110410415017100_R26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32831cec7b","article-title":"Imaging for large-vessel vasculitis","volume":"21","author":"Blockmans","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"2024110410415017100_R27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.181222","article-title":"Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis","volume":"47","author":"Banerjee","year":"2020","journal-title":"J Rheumatol"},{"key":"2024110410415017100_R28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024110410415017100_R29","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02171-6","article-title":"Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions","volume":"22","author":"Sugihara","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2024110410415017100_R30","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/mr\/roac122","article-title":"Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis","volume":"33","author":"Sugihara","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2024110410415017100_R31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/mr\/roab081","article-title":"Establishing clinical remission criteria and the framework of a treat-to-target\u00a0algorithm for Takayasu arteritis: results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitis","volume":"32","author":"Sugihara","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2024110410415017100_R32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/mr\/road046","article-title":"Establishing clinical remission criteria for giant cell arteritis: results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis","volume":"34","author":"Sugihara","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2024110410415017100_R33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00000658-198010000-00016","article-title":"Bowel perforation in steroid-treated patients","volume":"192","author":"ReMine","year":"1980","journal-title":"Ann Surg"},{"key":"2024110410415017100_R34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/14397595.2018.1496873","article-title":"Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease","volume":"29","author":"Ando","year":"2019","journal-title":"Mod Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roae034\/57504992\/roae034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/6\/1194\/60412097\/roae034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/6\/1194\/60412097\/roae034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T10:42:09Z","timestamp":1730716929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/34\/6\/1194\/7642501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2024,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roae034","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,4,8]]}}}